Daclatasvir plus asunaprevir dual therapy for chronic HCV genotype 1b infection: results of Turkish early access program. [electronic resource]
Producer: 20170228Description: 71-76 p. digitalISSN:- 1665-2681
- Aged
- Antiviral Agents -- adverse effects
- Carbamates
- Cost-Benefit Analysis
- Drug Costs
- Drug Therapy, Combination
- Female
- Genotype
- Health Services Accessibility -- economics
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- diagnosis
- Humans
- Imidazoles -- adverse effects
- Isoquinolines -- adverse effects
- Male
- Middle Aged
- Program Evaluation
- Pyrrolidines
- RNA, Viral -- genetics
- Sulfonamides -- adverse effects
- Time Factors
- Treatment Outcome
- Turkey
- Valine -- analogs & derivatives
- Viral Load
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.